3
Participants
Start Date
January 10, 2014
Primary Completion Date
October 22, 2014
Study Completion Date
October 22, 2014
Fentanyl Nasal Spray
100 mcg nasal spray administered in each nostril.
Hydromorphone PCA
Initial loading dose 0.2 mg with demand doses of 0.2 mg and lockout interval of 15 minutes. There will be no basal dose and the 8-hour dose limit will be 6.4 mg.
Placebo Nasal Spray
1 placebo nasal spray administered in each nostril.
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
Archimedes Pharma US, Inc.
INDUSTRY
M.D. Anderson Cancer Center
OTHER